188 related articles for article (PubMed ID: 33312423)
1. Screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry.
Khan M; Rauf W; Habib FE; Rahman M; Iqbal M
World J Hepatol; 2020 Nov; 12(11):976-992. PubMed ID: 33312423
[TBL] [Abstract][Full Text] [Related]
2. Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease.
Khan M; Rauf W; Habib FE; Rahman M; Iqbal S; Shehzad A; Iqbal M
BMC Complement Med Ther; 2022 Apr; 22(1):98. PubMed ID: 35366855
[TBL] [Abstract][Full Text] [Related]
3. Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease.
Fatima K; Tahir M; Qadri I
Virus Res; 2011 Sep; 160(1-2):230-7. PubMed ID: 21756947
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening of low molecular weight NS3-NS4A protease inhibitors using a fluorescence resonance energy transfer substrate.
Sudo K; Yamaji K; Kawamura K; Nishijima T; Kojima N; Aibe K; Shimotohno K; Shimizu Y
Antivir Chem Chemother; 2005; 16(6):385-92. PubMed ID: 16329285
[TBL] [Abstract][Full Text] [Related]
5. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
[TBL] [Abstract][Full Text] [Related]
6. Establishment and application of high throughput screening model for hepatitis C virus NS3-4A protease inhibitors in vitro.
Jian-rui L; Yan-bin W; Shu-yi S; Hong-shan C; Jian-dong J; Zong-gen B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):98-101. PubMed ID: 21375947
[TBL] [Abstract][Full Text] [Related]
7. HCV non-structural NS4A protein of genotype 3a induces mitochondria mediated death by activating Bax and the caspase cascade.
Javed F; Manzoor S
Microb Pathog; 2018 Nov; 124():346-355. PubMed ID: 30179714
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization and fluorescence analysis of HCV non-structural proteins NS3, NS3-4A and NS4A of genotype 3a.
Javed F; Manzoor S; Khattak AA; Imran M; Parvaiz F; Ashraf J; Tariq H; Bhatti S
Acta Virol; 2015 Sep; 59(3):284-94. PubMed ID: 26435152
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
10. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
[TBL] [Abstract][Full Text] [Related]
12. Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domain.
Ikram S; Ahmad J; Rehman IU; Durdagi S
J Mol Graph Model; 2020 Dec; 101():107727. PubMed ID: 33027738
[TBL] [Abstract][Full Text] [Related]
13. Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors.
Wright-Minogue J; Yao N; Zhang R; Butkiewicz NJ; Baroudy BM; Lau JY; Hong Z
J Hepatol; 2000 Mar; 32(3):497-504. PubMed ID: 10735621
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
[TBL] [Abstract][Full Text] [Related]
15. Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy.
Chusri P; Kumthip K; Pantip C; Thongsawat S; O'Brien A; Maneekarn N
Virus Res; 2015 Jan; 196():37-43. PubMed ID: 25445343
[TBL] [Abstract][Full Text] [Related]
16. 1
Omar AM; Elfaky MA; Arold ST; Soror SH; Khayat MT; Asfour HZ; Bamane FH; El-Araby ME
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32245218
[TBL] [Abstract][Full Text] [Related]
17. Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein.
Dimasi N; Pasquo A; Martin F; Di Marco S; Steinkühler C; Cortese R; Sollazzo M
Protein Eng; 1998 Dec; 11(12):1257-65. PubMed ID: 9930676
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
[TBL] [Abstract][Full Text] [Related]
19. Expression of a hepatitis C virus NS3 protease-NS4A fusion protein in Escherichia coli.
Inoue H; Sakashita H; Shimizu Y; Yamaji K; Yokota T; Sudo K; Shigeta S; Shimotohno K
Biochem Biophys Res Commun; 1998 Apr; 245(2):478-82. PubMed ID: 9571178
[TBL] [Abstract][Full Text] [Related]
20. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
